Publish Date: Sep 2020 |
Category: Healthcare, Pharmaceuticals & Medical Devices |
|
|
Publisher: BCC Research |
Status: Publish |
||
Report Scope:
This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the animal therapeutics and diagnostics market. The geographical scope of this study is worldwide, with special interest for markets, trends and statistics by key geographical regions such as the United States, European countries and Brazil, Japan and Australia. The report identifies markets in four segments: vaccines, pharmaceuticals, feed additives and diagnostics. For the purpose of this study, diagnostics include products that are used at the point of care and are considered rapid tests or kits, in-clinic analyzers and imaging equipment. Each market segment provides detailed information based on product categories, use of products, forecasts and competitive analyses.
Report Includes:
- An overview of the global markets for animal therapeutics and diagnostics
- Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021
- Details about products currently in the market
- Analysis of the competitive environment
- A look at keys to market success including identifying the next growth segment, developing the right product candidates, and being the first to market
- Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities
- Profiles of major players in the industry
REASONS FOR DOING THE STUDY
The animal health industry is responsible for maintaining the health and productivity of the more than 3 billion livestock and more than 50 billion poultry worldwide and
ensuring the wholesomeness and abundance of the food it produces. In addition, the industry must also cater to the health and well-being of companion animals. Despite
this, the human healthcare market is 30 times larger than the combined market for all nonhuman species. The reality is that the global animal health market is very complex, operating under stringent and increasingly strict regulations similar to those for human health, yet the market opportunities are considerably smaller. In an increasingly risky environment for new product development, the difference between success and failure in the future usually lies in successfully identifying the next growth segment, developing the right product candidates and being the first to market. Despite all these risks, the industry continues to grow.
In contrast to human blockbuster-oriented pharmaceuticals, animal health is dominated by a large number of products with small revenues. Although there are hundreds of products offered in the animal health market, only a couple dozen products have sales exceeding $100 million per year. However, the industry continues to forge on. The fastest growing therapeutic categories are in the area of companion animals, specifically in the allergy and respiratory and arthritis and pain segments of the market.
A challenging aspect of the animal health market is within the animal food industry as consumers continue to express concern about the conditions under which their daily food is produced. Consumers are becoming more health conscious and demanding healthy and balanced diets. The growing trend of natural and organic food is creating a niche market opportunity for suppliers. By implementing a feeding plan that provides vitamins and supplements, consumers enjoy additional nutritional benefits. Additionally, healthy feeding results in minimized impact on the environment.
SCOPE OF REPORT
This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the animal therapeutics and diagnostics market. The geographical scope of this study is worldwide, with special interest for markets, trends and statistics by key geographical regions such as the United States, European
countries and Brazil, Japan and Australia. The report identifies markets in four segments: vaccines, pharmaceuticals, feed additives and diagnostics. For the purpose of this study, diagnostics include products that are used at the point of care and are considered rapid tests or kits, in-clinic analyzers and imaging equipment. Each market segment provides detailed information based on product categories, use of products, forecasts and competitive analyses.